Skip to content

Treatment of endometrioma in infertile women

Comparison of ovarian response to ovulation induction after laparoscopic cystectomy or medical management among infertile women with endometrioma undergoing assisted reproductive technology

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201106116689N2
Enrollment
80
Registered
2012-11-05
Start date
2012-01-04
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Infertility. Condition 2: Endometriomas. ???????? ????? ????????????????????

Interventions

Intervention 1: First group receives 3 consecutive single IM doses of Dipherelin 3.75mg (Beaufouipfen, France) in 3 consecutive months.Ten days after the third IM dose of Dipherelin ovarian stimulatio
Siemens Medical Solutions, California, USA) is performed every 4 days. After the observation of at least two 18mm follicles, HCG (Ferring Co, Germany, 10000IU, IM) is injected and after 36 hours oocyt
the rate of fertilization, laboratory and clinical pregnancy are compared between two groups. Intervention 2: Second group receives 3 consecutive single IM doses of Dipherelin 3.75mg (Beaufouipfen, Fr
Treatment - Drugs
Treatment - Surgery
First group receives 3 consecutive single IM doses of Dipherelin 3.75mg (Beaufouipfen, France) in 3 consecutive months.Ten days after the third IM dose of Dipherelin ovarian stimulation is conducted b
Second group receives 3 consecutive single IM doses of Dipherelin 3.75mg (Beaufouipfen, France) in 3 consecutive months after laparoscopic ovarian cystectomy. Ten days after the third IM dose of Diphe

Sponsors

Vice Chancellor for Research, Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Infertile women with endometrioma requiring assisted reproductive technology Exclusion criteria: Age over 40 years; Endometrioma smaller than 2 cm or larger than 6 cm; Male infertility TESE (Testicular Sperm Extraction) or PESA (Percutaneous Epididimal Sperm Aspiration)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
The number of retrieved oocytes. Timepoint: 84 days after the first Dipherelin injection. Method of measurement: Invert Microscope, Diaphot 300, Nikon, Japan.

Secondary

MeasureTime frame
The number of dominant follicles. Timepoint: 82 days after the first Dipherelin injection. Method of measurement: nGS= number of observed gestatinal sac in trans vaginal sonography, nET= number of embryonal transfer, clinical pregnancy rate(%)= nGS/ nET x100.;Fertilization rate. Timepoint: 87 days after the first Dipherelin injection. Method of measurement: nE= number of total embryos, nI= number of injected oocytes, fertilization rate(%)= nE/ nI x 100.;The number and quality of embryos. Timepoint: 87 days after the first Dipherelin injection. Method of measurement: Invert Microscope, Diaphot 300, Nikon, Japan.;Chemical pregnancy. Timepoint: 101 days after the first Dipherelin injection. Method of measurement: ßhCG test.;Clinical pregnancy rate. Timepoint: 115 days after the first Dipherelin injection. Method of measurement: nGS= number of observed gestatinal sac in trans vaginal sonography, nET= number of embryonal transfer, clinical pregnancy rate(%)= nGS/ nET x100.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Sedighe Hoseinimosa

Tehran University of Medical Sciences, Shariati Hospital, Department of Infertility

hoseinimosa@razi.tums.ac.ir+98 21 8800 8810

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 11, 2026